- Filed
- Nov 7, 2024 12:00 AM ET
- Period of report
- —
Restated figures. One or more values in this filing restate previously reported amounts.
On SEC.gov
Financials in this filing
| Metric | Period | Value |
|---|---|---|
| Shares Diluted | FY 2024 · Mar 31, 2024 | 17.99M sh |
| Shares Diluted | FY 2024 · Mar 31, 2023 | 17.67M sh |
| Shares Diluted | FY 2024 · Mar 31, 2021 | 17.15M sh |
| Shares Outstanding | FY 2024 · Mar 31, 2024 | 17.71M sh |
| Operating Cash Flow | FY 2024 · Mar 31, 2024 | −$745.82K |
| Operating Cash Flow restated | FY 2024 · Mar 31, 2023 | −$1.03M |
| Long Term Debt | FY 2024 · Mar 31, 2024 | $1.89M |
| Short Term Debt | FY 2024 · Mar 31, 2024 | $1.56M |
| Short Term Debt | FY 2024 · Mar 31, 2023 | $1.36M |
| Cash And Equivalents | FY 2024 · Mar 31, 2024 | $145.26K |
| Cash And Equivalents | FY 2024 · Mar 31, 2023 | $277.84K |
| Stockholders Equity | FY 2024 · Mar 31, 2024 | −$204.55K |
| Stockholders Equity restated | FY 2024 · Mar 31, 2023 | −$698.88K |
| Current Liabilities | FY 2024 · Mar 31, 2024 | $2.48M |
| Current Liabilities restated | FY 2024 · Mar 31, 2023 | $2.21M |
| Total Liabilities | FY 2024 · Mar 31, 2024 | $3.39M |
| Total Liabilities restated | FY 2024 · Mar 31, 2023 | $2.82M |
| Current Assets | FY 2024 · Mar 31, 2024 | $2.03M |
| Current Assets restated | FY 2024 · Mar 31, 2023 | $1.04M |
| Total Assets | FY 2024 · Mar 31, 2024 | $3.17M |
| Total Assets restated | FY 2024 · Mar 31, 2023 | $2.13M |
| Eps Diluted | FY 2024 · Mar 31, 2024 | −$0.02 |
| Eps Diluted | FY 2024 · Mar 31, 2023 | $0.12 |
| Eps Diluted | FY 2024 · Mar 31, 2021 | $0.16 |
| Eps Basic | FY 2024 · Mar 31, 2024 | −$0.02 |
| Eps Basic | FY 2024 · Mar 31, 2023 | $0.12 |
| Eps Basic | FY 2024 · Mar 31, 2021 | $0.16 |
| Sga Expense | FY 2024 · Mar 31, 2024 | $897.52K |
| Sga Expense restated | FY 2024 · Mar 31, 2023 | $917.77K |
| Rd Expense | FY 2024 · Mar 31, 2024 | $493.84K |
| Rd Expense restated | FY 2024 · Mar 31, 2023 | $526.76K |
| Net Income | FY 2024 · Mar 31, 2024 | $271.87K |
| Net Income restated | FY 2024 · Mar 31, 2023 | −$2.2M |
| Operating Income | FY 2024 · Mar 31, 2024 | $266.56K |
| Operating Income restated | FY 2024 · Mar 31, 2023 | −$1.61M |
| Cost Of Revenue | FY 2024 · Mar 31, 2024 | $206.37K |
| Cost Of Revenue | FY 2024 · Mar 31, 2023 | $144.68K |
| Capex | FY 2024 · Mar 31, 2023 | $22.37K |
| Revenue | FY 2024 · Mar 31, 2022 | $2.33M |